Clinical management guidelines are typically focused on individual conditions and lack a robust evidence base for patients with MLTC. MLTC management is largely delivered in primary care, where health ...

Dr. Noritaka Ichinohe discusses three decades of translational neuroscience in a new Genomic Press Interview. His work links ...

Happy new year of reading! Have you started a great new book? Some of you overachievers have probably made use of the rainy weather to finish one or two already. There were hopeful stories, such as ...

It’s nearly time to say goodbye to 2025, but before we do, it’s worth noting one thing about the past year: The books were good. SEE ALSO: Like books? Get our free Book Pages newsletter about ...

The diversity of the general population is an important factor when determining the effectiveness of a new therapy. Although many trials are conducted on so-called experimental treatments, many ...

“In our rural region, as across the country, people are struggling with the cost of health care,” Stephen Leffler, M.D.’90, president and chief operating officer of the UVM Medical Center, CEO of UVM ...

Sickle cell disease, sleep disorders and lung cancer: these are just a few of the medical issues that were under investigation in at least 383 clinical trials that have had research grants terminated ...

A new $5.2 million grant from the Washington Research Foundation, or WRF, will help develop a new clinical trials program between Fred Hutch Cancer Center and Seattle Children’s Research Institute.

A new book titled Dianarama by author Andy Webb revisits the controversy surrounding Princess Diana's 1995 BBC Panorama interview with Martin Bashir. Webb investigates how false claims and deceptive ...